Myriad Genetics

Get Full Access

Description

  • Myriad Genetics, Inc., a molecular diagnostic company, develops and markets predictive, personalized, and prognostic medicine tests in the United States and internationally. The company offers myRisk Hereditary Cancer, a DNA sequencing test for hereditary cancers; BRACAnalysis, a DNA sequencing test to assess the risk of developing breast and ovarian cancer; and riskScore, a personalized medicine tool. It also provides BRACAnalysis CDx, a DNA sequencing test for use in identifying ovarian and HER2 negative metastatic breast cancer patients with deleterious or suspected deleterious germline; GeneSight, a DNA genotyping test to aid psychotropic drug selection for depressed patients; and Vectra, a protein quantification test for assessing the disease activity of rheumatoid arthritis. In addition, the company offers Foresight, a prenatal test for future parents to assess their risk of passing on a recessive genetic condition to their offspring; Prequel, a non-invasive prenatal screening test to screen for severe chromosomal disorders in a fetus; and Prolaris, a RNA expression test for assessing the aggressiveness of prostate cancer. Further, it provides EndoPredict, a RNA expression test for assessing the aggressiveness of breast cancer; myPath Melanoma, a RNA expression test for diagnosing melanoma; and myChoice CDx, a companion diagnostic to measure three modes of homologous recombination deficiency comprising loss of heterozygosity, telomeric allelic imbalance, and large-scale state transitions in cancer cells. Additionally, the company offers biomarker discovery, and pharmaceutical and clinical services to the pharmaceutical, biotechnology, and medical research industries; and operates an internal medicine emergency hospital primarily for internal medicine and hemodialysis. It has a a strategic collaboration with Illumina, Inc. Myriad Genetics, Inc. was founded in 1991 and is headquartered in Salt Lake City, Utah.
  • location

    Headquarters:320 Wakara Way , Salt Lake City, Utah, United States

    More
  • Myriad Genetics phone

    Phone Number: +1 801-584-3600

  • Myriad Genetics website

    Website: https://www.myriad.com

  • Myriad Genetics employees

    Employees:2111

  • Myriad Genetics revenue

    Revenue:$500M - 1B

  • Myriad Genetics legal name

    Legal Name:Myriad Genetics

  • Myriad Genetics's Social Media

    Myriad Genetics linkedin Myriad Genetics facebook Myriad Genetics twitter
  • done Is this data correct?
  • |  NAICS Code: 621511  |

      NYSE: MYGN

    Show More
Person level website identification

CEO for Myriad Genetics

Jihn Jhuni

Chief Executive Officer

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Kevin Haas

Chief Technology Officer

Mark Skolnick

Chief Strategy Officer

Bryan Riggsbee

Executive Vice President - Chief Financial Officer At Myriad Genetics

Mark Verratti

President

Nicole Lambert

Chief Operating Officer

Frequently Asked Questions regarding Myriad Genetics

  • Where are Myriad Genetics's Headquarters?

    Myriad Genetics's Headquarters are in 320 Wakara Way ,Salt Lake City,Utah,United States

  • What is Myriad Genetics's phone number?

    Myriad Genetics's phone number is +1 801-584-3600

  • What is Myriad Genetics's stock symbol?

    Myriad Genetics's stock symbol is MYGN

  • What is Myriad Genetics's official website?

    Myriad Genetics's official website is https://www.myriad.com

  • What is Myriad Genetics's Revenue?

    Myriad Genetics's revenue is $500M - 1B

  • What is Myriad Genetics's NAICS code?

    Myriad Genetics's NAICS code is 621511

  • How many employees are working in Myriad Genetics

    Myriad Genetics has 2111 employees

  • What is Myriad Genetics's Industry?

    Myriad Genetics is in the industry of Medical Devices

Company Directory